What is the most appropriate treatment for a patient with acute kidney injury (AKI) and signs of volume depletion, including orthostasis and dry mucous membranes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Kidney Injury with Volume Depletion

IV 0.9% sodium chloride is the most appropriate treatment for this patient's acute kidney injury (AKI) with clear signs of volume depletion. 1

Assessment of the Patient's AKI

The patient presents with several key findings indicating prerenal AKI due to volume depletion:

  • Physical examination reveals dry mucous membranes and orthostasis
  • Laboratory findings show urine sodium of 19 mEq/L and FENa of 0.9% (both consistent with prerenal AKI)
  • Vital signs show relative hypotension (110/68 mmHg) and bradycardia (53 beats/min)

These findings collectively point to hypovolemic AKI, which requires prompt volume restoration.

Treatment Approach

First-Line Treatment

  • IV 0.9% sodium chloride is the first-line therapy for hypovolemic AKI according to KDIGO guidelines 1
  • The goal is to restore effective circulating volume to improve renal perfusion
  • Isotonic crystalloids are preferred over colloids for initial management of AKI 1, 2

Inappropriate Treatment Options

  • IV 6% hetastarch is contraindicated in AKI as starch-containing fluids can worsen renal function 1
  • IV low-dose dopamine should not be used to prevent or treat AKI (Level 1A evidence against its use) 1
  • Oral tamsulosin has no role in the management of hypovolemic AKI

Medication Management

The patient is currently on several medications that may contribute to or worsen AKI:

  • Hold canagliflozin - SGLT2 inhibitors can exacerbate volume depletion and worsen AKI
  • Hold losartan - ARBs can impair renal autoregulation, especially in volume-depleted states
  • Hold metformin - Should be temporarily discontinued until renal function improves to prevent lactic acidosis

Monitoring and Reassessment

After initiating IV fluid therapy:

  • Track urine output and vital signs closely
  • Monitor serum creatinine and electrolytes every 24-48 hours
  • Be vigilant for signs of fluid overload as resuscitation progresses
  • Watch for hyperchloremic metabolic acidosis with large volumes of normal saline 1, 3

Fluid Management Strategy

A three-phase approach is optimal for fluid management in AKI 3:

  1. Initial resuscitation phase: Guided fluid resuscitation with IV 0.9% sodium chloride
  2. Maintenance phase: Achieve neutral fluid balance once hemodynamically stable
  3. Recovery phase: Consider careful fluid removal if fluid overload develops

Pitfalls to Avoid

  • Overzealous fluid administration leading to fluid overload, which can delay renal recovery and increase mortality 4, 3
  • Inadequate volume resuscitation, which may perpetuate renal hypoperfusion
  • Failure to discontinue nephrotoxic medications during AKI
  • Relying solely on static measurements like central venous pressure for assessing fluid responsiveness 2

Dynamic assessment of fluid status throughout treatment is essential for optimizing outcomes in this patient with hypovolemic AKI.

References

Guideline

Acute Kidney Injury Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fluid Management in Acute Kidney Injury.

Contributions to nephrology, 2016

Research

Fluid balance and acute kidney injury.

Nature reviews. Nephrology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.